Cripps A W, Dunkley M L, Clancy R L
Hunter Area Health Service, John Hunter Hospital, Newcastle, New South Wales, Australia.
Infect Immun. 1994 Apr;62(4):1427-36. doi: 10.1128/iai.62.4.1427-1436.1994.
The aim of this study was to determine the efficacies of prior mucosal (oral, intra-Peyer's patch, or intratracheal) and systemic (subcutaneous) immunizations with killed Pseudomonas aeruginosa in clearance of an acute P. aeruginosa respiratory infection in rats. Rats were immunized with paraformaldehyde-killed P. aeruginosa at various doses, and 2 weeks later, the rats were challenged with a log10 dose of 8.7 live bacteria. This dose was fatal for unimmunized rats, with death occurring approximately 12 h after challenge. The numbers of surviving bacteria in the airways and lung tissue were determined by analyses of bronchoalveolar lavage fluid (BAL) and lung homogenate samples, respectively. Enhanced bacterial clearance was associated with survival of intra-Peyer's patch-immunized rats. Determination of bacterial clearance in BAL 4 h after challenge demonstrated that the use of all immunization routes led to significant clearance compared with the bacterial levels in unimmunized controls (the order of effectiveness was intra-Peyer's patch > oral-intratracheal > intratracheal > subcutaneous > oral). Bacterial clearance in the lung homogenate was also significantly greater for all immunization routes than in the unimmunized controls (the order of effectiveness was intra-Peyer's patch > subcutaneous > oral-intratracheal > oral = intratracheal). Prior oral immunization with killed P. aeruginosa also induced enhanced bacterial clearance of heterologous strains of P. aeruginosa, Haemophilus influenzae, and to a lesser extent, Klebsiella pneumoniae. Because of the ease of antigen delivery, oral immunization with killed P. aeruginosa may be an important route of immunization for induction of enhanced bacterial clearance of subsequent acute respiratory infection with P. aeruginosa and other gram-negative bacteria.
本研究的目的是确定用灭活铜绿假单胞菌进行预先黏膜(口服、派伊尔结内、或气管内)和全身(皮下)免疫在清除大鼠急性铜绿假单胞菌呼吸道感染方面的效果。用不同剂量的多聚甲醛灭活铜绿假单胞菌对大鼠进行免疫,2周后,用对数10剂量为8.7的活细菌对大鼠进行攻击。该剂量对未免疫的大鼠是致命的,攻击后约12小时死亡。分别通过分析支气管肺泡灌洗液(BAL)和肺匀浆样本确定气道和肺组织中存活细菌的数量。派伊尔结内免疫的大鼠存活与细菌清除增强有关。攻击后4小时测定BAL中的细菌清除情况表明,与未免疫对照组的细菌水平相比,所有免疫途径的使用均导致显著的细菌清除(有效性顺序为派伊尔结内>口服-气管内>气管内>皮下>口服)。所有免疫途径在肺匀浆中的细菌清除也显著高于未免疫对照组(有效性顺序为派伊尔结内>皮下>口服-气管内>口服 = 气管内)。用灭活铜绿假单胞菌进行预先口服免疫也诱导了对铜绿假单胞菌、流感嗜血杆菌以及程度较轻的肺炎克雷伯菌异源菌株的细菌清除增强。由于抗原递送简便,用灭活铜绿假单胞菌进行口服免疫可能是诱导对随后铜绿假单胞菌和其他革兰氏阴性菌急性呼吸道感染增强细菌清除的重要免疫途径。